-+ 0.00%
-+ 0.00%
-+ 0.00%

NOVO NORDISK CSO: WE WANT TO BRING ORAL AND SUBCUTANEOUS ZENAGAMTIDE TO THE MARKET SIMULTANEOUSLY

路透·09/21/2026 10:03:24

請登錄查看新聞詳情